By Sopuruchi Onwuka

Nigeria-born Imperial College London professor and winner of the 2023 Nigeria Prize for Science, Professor Hippolite Amadi, has embarked on a nationwide expansion of his groundbreaking JaundiRoom initiative, a pioneering neonatal healthcare intervention designed to provide rapid, effective and affordable treatment for neonatal jaundice in rural and underserved communities across Nigeria.

Prof Hippolite Amadi

The expansion marks the latest phase in a nearly four-decade scientific mission by the Nigerian-born biomedical innovator to eliminate preventable newborn deaths through indigenous technologies tailored to the realities of low-resource environments.

As part of the nationwide rollout of the initiative, Professor Amadi commissioned a new JaundiRoom facility on June 25 at Eleta, near Ibadan in Oyo State, where the centre is expected to provide efficient and affordable treatment for newborn babies suffering from neonatal jaundice.

The commissioning represents another milestone in Professor Amadi’s broader strategy to establish a nationwide network of specialized jaundice treatment facilities capable of delivering life-saving interventions in communities where specialist healthcare services, reliable electricity and advanced medical infrastructure remain either inadequate or entirely absent.

The JaundiRoom project, which medical experts regard as one of the most important indigenous innovations in neonatal healthcare in recent years, addresses one of the leading causes of preventable infant mortality and lifelong neurological disability in low- and middle-income countries.

Through the deployment of specialized, solar-powered intensive phototherapy systems, the initiative seeks to bridge longstanding gaps in access to quality neonatal care and provide effective treatment to millions of vulnerable newborns across Nigeria.

For Professor Amadi, however, the JaundiRoom initiative represents more than another scientific breakthrough. Rather, it constitutes the culmination of decades of interdisciplinary research and innovation aimed at confronting the four principal causes of newborn mortality in resource-constrained environments.

According to him, these challenges include thermal instability, respiratory distress, inadequate power supply and neonatal jaundice.

While acknowledging that his earlier innovations in neonatal respiratory support earned him the prestigious Nigeria Prize for Science in 2023, Professor Amadi said he considers the JaundiRoom initiative potentially even more impactful because of its capacity to prevent irreversible brain injury and death among newborn babies on a large scale.

He commended the Nigeria LNG Limited (NLNG) for establishing and sustaining the Nigeria Prize for Science, observing that the company had assumed a role that public health institutions and ministries at the various levels of government in Nigeria had largely neglected.

Although he did not rule out the possibility of submitting the JaundiRoom initiative for future editions of the Nigeria Prize for Science if the appropriate category emerges, he emphasized that his interventions have never been driven by commercial motives.

“I prefer partnership with people seeking to assist the poor, the rural, the neglected, the underserved,” he said.

Professor Amadi explained that neonatal jaundice remains one of the most underestimated public health challenges in Nigeria and many developing countries. Caused by excessive accumulation of bilirubin in the bloodstream, severe neonatal jaundice can rapidly progress to permanent brain damage, hearing impairment, cerebral palsy, intellectual disability or death if not promptly treated during the critical first days of life.

According to him, conventional treatment methods often require prolonged hospitalization, expensive infrastructure and specialist personnel, rendering effective care inaccessible to millions of families residing in rural and underserved communities.

The JaundiRoom concept, therefore, was developed as a practical and sustainable intervention capable of overcoming the infrastructural limitations that characterize much of Nigeria’s healthcare system.

At the centre of the initiative is an advanced intensive phototherapy technology developed using locally sourced materials and designed to operate entirely on solar power. Professor Amadi disclosed that the system provides total body irradiation levels ranging from 45 to 158 µW/cm²/nm at therapeutic wavelengths of approximately 460 nanometres.

“The system provides total body irradiation levels ranging from 45 to 158 µW/cm²/nm at therapeutic wavelengths of approximately 460 nanometres, making it one of the most powerful phototherapy technologies available globally for the treatment of neonatal jaundice,” he declared.

He further revealed that clinical trials conducted at the University of Calabar Teaching Hospital demonstrated exceptional treatment outcomes, with newborn babies suffering from severe hyperbilirubinaemia successfully treated within an average period of approximately 18 hours without adverse effects.

According to him, this treatment duration compares favourably with conventional therapies that often require several days of hospitalization.

Professor Amadi emphasized that one of the most significant strengths of the JaundiRoom model lies in its ability to provide specialized neonatal care in environments characterized by shortages of neonatologists, unreliable electricity supplies and weak medical infrastructure.

He explained that the facilities operate continuously using real-time solar energy while simultaneously storing reserve power sufficient to sustain treatment for more than 27 hours in the absence of sunlight.

“The objective has always been to create solutions that do not depend on systems that routinely fail our people,” Professor Amadi explained. “When you understand the problem completely, you can design solutions that remain effective regardless of the environment.”

The JaundiRoom initiative represents the fourth pillar of Professor Amadi’s broader scientific programme aimed at eliminating preventable newborn deaths through indigenous technological innovation. His earlier interventions addressed neonatal temperature regulation, sustainable power supply for neonatal intensive care units and respiratory support systems for premature babies.

Together, these innovations constitute one of the most comprehensive frameworks ever developed by an African scientist for tackling the principal causes of neonatal mortality in low-resource settings.

Remarkably, Professor Amadi has financed much of this work through personal resources, facilitating the installation of life-saving neonatal technologies in several tertiary and secondary healthcare institutions across Nigeria. According to him, his commitment has always been to saving newborn lives rather than pursuing commercial profits.

He argued that indigenous innovation remains essential for improving healthcare outcomes in Nigeria because many imported technologies are designed for healthcare systems operating under vastly different environmental and infrastructural conditions.

He noted that several conventional phototherapy devices currently used in Nigerian hospitals deliver inadequate treatment intensity, thereby prolonging hospitalization periods and increasing the risk of complications.

The nationwide expansion of the JaundiRoom initiative therefore represents not only a significant advancement in neonatal healthcare delivery but also a compelling demonstration of the transformative potential of locally developed medical technologies.

The initiative could significantly reduce infant mortality, prevent lifelong neurological disabilities and improve healthcare equity across Nigeria by bringing effective jaundice treatment closer to vulnerable populations in rural and underserved communities.

For Professor Amadi, however, the ultimate objective remains straightforward: to ensure that no Nigerian child suffers permanent injury or dies from a treatable condition simply because of the circumstances or location of birth.

The growing national visibility of Professor Amadi’s work owes much to the Nigeria Prize for Science, established and sponsored by Nigeria LNG Limited as part of its broader corporate social responsibility framework.

Although Professor Amadi had spent nearly four decades quietly building one of Africa’s most remarkable records of scientific innovation, his groundbreaking contributions remained largely confined to specialist scientific and medical communities until his emergence as the winner of the 2023 edition of the prestigious prize.

The recognition of Professor Amadi by the Nigeria Prize for Science not only celebrated the extraordinary achievements of an individual scientist but also illuminated the transformative potential of indigenous innovation, interdisciplinary scholarship and socially responsive scientific research.

Widely regarded as Africa’s foremost scientific award, the Nigeria Prize for Science was instituted by NLNG to promote scientific excellence and encourage research capable of addressing critical developmental challenges affecting humanity.

In selecting Professor Amadi as the 2023 laureate, the prize committee effectively brought national and international attention to a scientist whose life’s work embodies the principles of innovation, social impact and sustainable development that underpin the philosophy of the award.

Evidently, Professor Amadi’s career represents a uniquely African model of scientific innovation built upon affordability, accessibility, sustainability and social equity. His life’s mission has been driven by a conviction that poverty, geography, inadequate infrastructure and circumstances of birth should never determine whether a newborn child lives or dies.

The irony, however, is that Professor Amadi’s scientific journey began far from the sophisticated medical laboratories where he would eventually establish his global reputation. He obtained his undergraduate education in Mechanical and Production Engineering at Enugu State University of Science and Technology, graduating in 1988 with strong foundations in systems engineering, mechanics and industrial problem-solving.

Amadi subsequently earned a master’s degree in engineering in Nigeria before embarking on an intellectual journey that would eventually bridge engineering, medicine and public health.

After nearly a decade of applying engineering principles to healthcare challenges, he proceeded to the United Kingdom, where he obtained both a Master of Science degree and a Doctor of Philosophy degree at Imperial College London. His doctoral research in orthopaedic biomechanics produced a groundbreaking mathematical model that established the relationship between the capsular insertion neck and the anatomical neck of the human proximal humerus, significantly improving predictive planning tools used in shoulder surgery.

Yet despite the promise of a distinguished career in orthopaedic science, Professor Amadi became increasingly troubled by the realities confronting newborn babies in Nigeria and other developing countries, where thousands died annually from preventable conditions due to inadequate healthcare infrastructure, unreliable electricity supplies and shortages of specialist personnel.

This realization fundamentally transformed the trajectory of his scientific career. Over the next three decades, Professor Amadi developed one of the most comprehensive programmes of neonatal healthcare innovation ever undertaken by an African scientist.

Through Neonatal Concerns for Africa, the charity organization he established in 2000, he built one of the continent’s largest neonatal research and intervention networks, spanning more than 30 tertiary hospitals across Nigeria’s six geopolitical zones and generating nationally representative clinical evidence on newborn health.

His first major intervention addressed neonatal thermal instability through the development of the Recycled Incubator Technology programme in 2003. Rather than depending on expensive imported equipment, Professor Amadi pioneered a system for refurbishing obsolete incubators into modern thermal support systems adapted to local conditions.

Beginning in 2005, Prof Amadi collaborated with healthcare institutions nationwide to deploy these systems, significantly expanding access to neonatal thermal care.

He subsequently developed additional interventions, including the identification of Tropical Evening Fever Syndrome in neonates, therapeutic approaches to neonatal hyperthermia and the Handy Approach and HISA algorithm for neonatal thermal management.

In recognizing that effective neonatal care depends fundamentally on reliable electricity, Professor Amadi later developed solar-powered neonatal support systems incorporating renewable energy generation, battery storage and energy management technologies.

The innovations effectively eliminated dependence on unreliable public electricity infrastructure and created opportunities for establishing neonatal intensive care facilities in remote communities.

His third major area of intervention focused on neonatal respiratory distress syndrome. To address the prohibitive costs associated with conventional respiratory support technologies, Professor Amadi developed several indigenous respiratory care devices specifically designed for low-resource settings. These included the Politeheart bubble continuous positive airway pressure system introduced in 2017, the Polite Oxygen Supply Splitter System and the PoliteO₂Blend oxygen-air blending technology developed in 2019.

These innovations significantly improved access to respiratory care while reducing dependence on imported equipment. It was principally these contributions that earned Professor Amadi the Nigeria Prize for Science in 2023 and established him among Africa’s leading biomedical innovators.

Yet, Professor Amadi’s scientific quest did not end there; his recent focus on severe neonatal jaundice led to the development of the JaundiRoom initiative and the associated PoliteUltraLumen phototherapy system, which he regards as the potentially final component of his integrated neonatal mortality reduction strategy.

Clinical trials demonstrated that the technology could safely reduce severe bilirubin levels within approximately 19 hours while significantly reducing the risk of permanent neurological injury and death.

Equally important, the system was designed to be operated by healthcare personnel with basic training, thereby extending access to life-saving treatment beyond specialist hospitals.

Throughout his career, Professor Amadi’s innovations have distinguished themselves not only by scientific sophistication but also by an unwavering commitment to social justice and healthcare accessibility.

Prof Amadi disclosed that virtually all the devices and facilities incorporated into his innovations are handcrafted and designed specifically for rural communities, underserved populations and healthcare institutions operating under severe resource constraints.

It is precisely this philosophy that explains the profound resonance between Professor Amadi’s life’s work and the corporate social responsibility agenda of Nigeria LNG Limited. Since establishing the Nigeria Prize for Science in 2004, NLNG has consistently sought to promote scientific research capable of generating transformative social impact and addressing critical developmental challenges.

Beyond the prize itself, the company’s corporate social responsibility portfolio encompasses educational scholarships, healthcare interventions, community development projects, social infrastructure investments and human capital development programmes across Nigeria.

These initiatives reflect NLNG’s commitment to sustainable development, community empowerment and equitable access to opportunities and essential services.

The convergence between NLNG’s developmental philosophy and Professor Amadi’s scientific mission is therefore both profound and instructive. Like NLNG’s investments in underserved communities, Professor Amadi’s innovations are designed to reach populations often excluded from the benefits of modern healthcare systems.

Like the company’s emphasis on sustainability and local capacity development, his technologies prioritize indigenous solutions, renewable energy and contextual adaptation.

As a globally recognized researcher, educator and innovator, Professor Hippolite Amadi stands today as one of Africa’s most compelling examples of how scientific excellence, humanitarian commitment and indigenous innovation can combine to transform millions of lives.

While the Nigeria Prize for Science may have brought his extraordinary achievements into public view, his true legacy lies elsewhere: in the countless premature babies who survived through his respiratory support systems, the newborns whose body temperatures were stabilized by his incubators, the infants whose jaundice was successfully treated through his phototherapy technologies and the families in remote communities whose children survived because one Nigerian scientist refused to accept that poverty, geography and weak infrastructure should determine who lives and who dies.